These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8263156)

  • 61. The antiemetic profile of zacopride.
    Smith WL; Alphin RS; Jackson CB; Sancilio LF
    J Pharm Pharmacol; 1989 Feb; 41(2):101-5. PubMed ID: 2568416
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A double-blind dose ranging study of BRL 24924 and metoclopramide on lower oesophageal sphincter pressure in healthy volunteers.
    Robertson CS; Ledingham SJ; Cooper SM; Evans DF
    Br J Clin Pharmacol; 1989 Sep; 28(3):323-7. PubMed ID: 2789926
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effect of metoclopramide, ondansetron and granisetron on aldosterone secretion in man.
    Sommers DK; Snyman JR; van Wyk M
    Eur J Clin Pharmacol; 1993; 44(4):337-9. PubMed ID: 8390368
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Are there changes in sensitivity to 5-HT3 receptor ligands following chronic diazepam treatment?
    Andrews N; File SE
    Psychopharmacology (Berl); 1992; 108(3):333-7. PubMed ID: 1523283
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Handling history of rats modifies behavioural effects of drugs in the elevated plus-maze test of anxiety.
    Andrews N; File SE
    Eur J Pharmacol; 1993 Apr; 235(1):109-12. PubMed ID: 8519271
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pharmacological and molecular characterization of 5-hydroxytryptamine(7) receptors in the rat adrenal gland.
    Contesse V; Lenglet S; Grumolato L; Anouar Y; Lihrmann I; Lefebvre H; Delarue C; Vaudry H
    Mol Pharmacol; 1999 Sep; 56(3):552-61. PubMed ID: 10462543
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Zacopride: anxiolytic profile in rodent and primate models of anxiety.
    Costall B; Domeney AM; Gerrard PA; Kelly ME; Naylor RJ
    J Pharm Pharmacol; 1988 Apr; 40(4):302-5. PubMed ID: 2900320
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Zacopride stimulates 5-HT
    Neumann J; Hesse C; Hofmann B; Gergs U
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Apr; ():. PubMed ID: 38557827
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Zacopride, a 5-HT3 receptor antagonist, reduces voluntary ethanol consumption in rats.
    Knapp DJ; Pohorecky LA
    Pharmacol Biochem Behav; 1992 Apr; 41(4):847-50. PubMed ID: 1594653
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The effects of tacrine and zacopride on the performance of adult rats in the working memory task.
    Jäkälä P; Sirviö J; Riekkinen PJ
    Gen Pharmacol; 1993 May; 24(3):675-9. PubMed ID: 8365650
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The emetic activity of centrally administered cisplatin in cats and its antagonism by zacopride.
    Smith WL; Callaham EM; Alphin RS
    J Pharm Pharmacol; 1988 Feb; 40(2):142-3. PubMed ID: 2897451
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Enhancement of antithrombotic effect of aspirin by metoclopramide in rats.
    Mobarok Ali AT; al-Humayyd MS
    Thromb Res; 1991 Feb; 61(4):361-7. PubMed ID: 1648276
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effect of the novel 5-HT4 receptor agonist DAU 6236 in human colon.
    McLean PG; Coupar IM; Molenaar P
    Med J Aust; 1993 Dec 6-20; 159(11-12):834. PubMed ID: 8264483
    [No Abstract]   [Full Text] [Related]  

  • 74. [Effect of metoclopramide and acth on aldosterone secretion in patients with insufficiency of the anterior pituitary gland].
    Słowińska-Srzednicka J; Zgliczyński S; Puciłowska J; Kasperlik-Załuska A; Snochowska H
    Pol Arch Med Wewn; 1985 Oct; 74(4):250-60. PubMed ID: 3880298
    [No Abstract]   [Full Text] [Related]  

  • 75. Quantitative measurement of zacopride in human plasma and urine by combined gas chromatography/negative ion chemical ionization mass spectrometry.
    Girault J; Longueville D; Ntzanis L; Couffin S; Fourtillan JB
    Biol Mass Spectrom; 1994 Sep; 23(9):572-80. PubMed ID: 7948050
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The serotonin 5-HT4 receptor. 1. Design of a new class of agonists and receptor map of the agonist recognition site.
    Buchheit KH; Gamse R; Giger R; Hoyer D; Klein F; Klöppner E; Pfannkuche HJ; Mattes H
    J Med Chem; 1995 Jun; 38(13):2326-30. PubMed ID: 7608898
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Comparison of routes of administration and time course effects of zacopride and buspirone in mice using an automated light/dark test.
    Young R; Johnson DN
    Pharmacol Biochem Behav; 1991 Dec; 40(4):733-7. PubMed ID: 1687761
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Regulation of plasma aldosterone levels by metoclopramide: a reappraisal of its mechanism from dopaminergic antagonism to serotonergic agonism.
    Rizzi CA; Mierau J; Ladinsky H
    Neuropharmacology; 1997 Jun; 36(6):763-8. PubMed ID: 9225303
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Design, synthesis and evaluation of bicyclic benzamides as novel 5-HT1F receptor agonists.
    Zhang D; Kohlman D; Krushinski J; Liang S; Ying BP; Reilly JE; Dinn SR; Wainscott DB; Nutter S; Gough W; Nelson DL; Schaus JM; Xu YC
    Bioorg Med Chem Lett; 2004 Dec; 14(24):6011-6. PubMed ID: 15546719
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Zacopride in schizophrenia: a single-blind serotonin type 3 antagonist trial.
    Newcomer JW; Faustman WO; Zipursky RB; Csernansky JG
    Arch Gen Psychiatry; 1992 Sep; 49(9):751-2. PubMed ID: 1514881
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.